Skip to main content
TipRanks
Go Ultimate75% OFF

Marcus Wolfinger Insider Profile

4 Followers

Marcus Wolfinger, Chairman & Chief Executive Officer at STRATEC Biomedical, holds ― shares in STRATEC Biomedical (Ticker: GB:0RAR). Most recently, Marcus Wolfinger Bought 150 shares of STRATEC Biomedical on Mar 17, 2023 for an estimated value of €10.13K.

Marcus Wolfinger's Trading History

0RAR
STRATEC Biomedical
Mar 17, 2023Chairman & Chief Executive OfficerInformative Buy10.13K―
GB:0RAR
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 17, 2023Informative Buy€10.13K150€67.50-34.60%―
Mar 15, 2023Informative Buy€10.08K145€69.50-36.60%―
Mar 13, 2023Informative Buy€14.65K220€66.60-33.10%―
Mar 10, 2023Informative Buy€13.74K200€68.70-33.50%―
Nov 16, 2022Informative Sell€317.06K3,500€90.59+24.20%―

You May Also Like

Marcus Wolfinger insider profile FAQ

What is the percentage of profitable transactions made by Marcus Wolfinger?
The percentage of profitable transactions made by Marcus Wolfinger is 36%.
What is the average return per transaction made by Marcus Wolfinger?
The average return per transaction made by Marcus Wolfinger is -10.70%.
What stocks does Marcus Wolfinger hold?
Marcus Wolfinger holds: GB:0RAR stocks.
What was Marcus Wolfinger’s latest transaction?
Marcus Wolfinger’s latest transaction was an Informative Buy of €10.13K.
What was Marcus Wolfinger's most profitable transaction?
Marcus Wolfinger’s most profitable transaction was an Informative Sell of GB:0RAR stock on June 14, 2018. The return on the trade was 30.90%.
What is Marcus Wolfinger's role in STRATEC Biomedical?
Marcus Wolfinger's role in STRATEC Biomedical is Chairman & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.